Encephalopathy and myoclonus triggered by valproic acid

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 6, 2004, Pages 1061-1063

  Reif, Andreas ^a   Leonhard, Christine ^a   Mößner, Rainald ^a   Lesch, Klaus Peter ^a   Fallgatter, Andreas J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Ammonemia; EEG; Electroencephalography; Encephalopathy; Myoclonus; Side effect; Slowing; Valproic acid

Indexed keywords

ACARBOSE; AMITRIPTYLINE; CLOMIPRAMINE; FLUPENTIXOL; LITHIUM; MIRTAZAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; ANAMNESIS; ARTICLE; BRAIN DISEASE; CASE REPORT; CONFUSION; DEPRESSIVE PSYCHOSIS; DIABETES MELLITUS; DRUG TOLERANCE; FLAPPING TREMOR; GAIT DISORDER; HUMAN; MALE; MYOCLONUS; NAUSEA; TREMOR;

ADULT; ANTIMANIC AGENTS; BRAIN DISEASES; ELECTROENCEPHALOGRAPHY; HUMANS; MALE; MYOCLONUS; VALPROIC ACID;

EID: 4544290314     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.05.041     Document Type: Article

References (15)

1. U. Aguglia, A. Gambardella, M. Zappia, P. Valentino, and A. Quattrone Negative myoclonus during valproate-related stupor. Neurophysiological evidence of a cortical non-epileptic origin Electroencephalogr. Clin. Neurophysiol. 94 1995 103 108
2. C. Armon, C. Shin, P. Miller, S. Carwile, E. Brown, J.D. Edinger, and R.G. Paul Reversible parkinsonism and cognitive impairment with chronic valproate use Neurology 47 1996 626 635
3. L. Averbuch-Heller, T. Ben-Hur, and A. Reches Valproate encephalopathy and hypocarnitinaemia in diabetic patients J. Neurol. 241 1994 567 569
4. C.L. Bowden Valproate Bipolar Disord. 5 2003 189 202
5. W.T. Chen, D.J. Yen, H.Y. Yu, and K.K. Liao Valproate-induced encephalopathy Zhonghua Yixue Zazhi (Taipei) 64 2001 474 478
6. J.C. DeToledo, H. Haddad, and R.E. Ramsay Status epilepticus associated with the combination of valproic acid and clomipramine Ther. Drug Monit. 19 1997 71 73
7. V. Farkas, M. Szabo, I. Renyi, O. Kohlheb, and C. Benninger Temporary pure red-cell aplasia during valproate monotherapy: clinical observations and spectral electroencephalographic aspects J. Child Neurol. 15 2000 485 487
8. C. Fehr, G. Grunder, C. Hiemke, and N. Dahmne Increase in serum clomipramine concentrations caused by valproate J. Clin. Psychopharmacol. 20 2000 493 494
9. H. Gastaut, and F. Iemolo Stuporous states or coma induced by the rapid administration of high doses of sodium valproate Ital. J. Neurol. Sci. 3 1982 193 196
10. E. Perucca Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience CNS Drugs 16 2002 695 714
11. A. Reif, B. Hamelbeck, and B. Pfuhlmann Acute akinetic crisis with marked cognitive impairment due to valproate treatment Int. J. Geriatr. Psychiatry 18 2003 356 357
12. K.G. Rottach, J. Weiss-Brummer, U. Wieland, and M. Schmauss Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy Nervenarzt 71 2000 401 403
13. M.E. Sobaniec-Lotowska, and W. Sobaniec Morphological features of encephalopathy after chronic treatment of the antiepileptic drug valproate to rats. A transmission electron microscopic study of capillaries in the cerebellar cortex Exp. Toxicol. Pathol. 48 1996 65 75
14. A. Verrotti, D. Trotta, G. Morgese, and F. Chiarelli Valproate-induced hyperammonemic encephalopathy Metab. Brain Dis. 17 2002 367 373
15. D.G. Vossler, A.J. Wilensky, D.F. Cawthon, D.L. Kraemer, L.M. Ojemann, L.M. Caylor, and J.D. Morgan Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy Epilepsia 43 2002 154 159